Smadとは? わかりやすく解説

Weblio 辞書 > 辞書・百科事典 > 百科事典 > Smadの意味・解説 

Smad

出典: フリー百科事典『ウィキペディア(Wikipedia)』 (2024/03/26 13:45 UTC 版)

SmadまたはSMADは、TGF-βスーパーファミリーに対する受容体からのシグナルの主要な伝達因子となる、構造的に類似したタンパク質群からなるタンパク質ファミリーである。Smadは細胞の発生や成長の調節に非常に重要である。Smadという名称は、線虫Caenorhabditis elegansのSMA("small" worm phenotype)やショウジョウバエDrosophilaMADファミリー英語版("Mothers Against Decapentaplegic")との相同性に由来する。


  1. ^ dpp母性効果英語版を強化するためこの名称が付けられた[9]
  1. ^ “Smads: transcriptional activators of TGF-beta responses”. Cell 95 (6): 737–40. (December 1998). doi:10.1016/S0092-8674(00)81696-7. PMID 9865691. 
  2. ^ “Smad transcription factors”. Genes & Development 19 (23): 2783–810. (December 2005). doi:10.1101/gad.1350705. PMID 16322555. 
  3. ^ “Crystal structure of a phosphorylated Smad2. Recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-beta signaling”. Molecular Cell 8 (6): 1277–89. (December 2001). doi:10.1016/S1097-2765(01)00421-X. PMID 11779503. 
  4. ^ “TGFβ signalling in context”. Nature Reviews Molecular Cell Biology 13 (10): 616–30. (October 2012). doi:10.1038/nrm3434. PMC 4027049. PMID 22992590. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027049/. 
  5. ^ “A structural basis for mutational inactivation of the tumour suppressor Smad4”. Nature 388 (6637): 87–93. (July 1997). Bibcode1997Natur.388R..87S. doi:10.1038/40431. PMID 9214508. 
  6. ^ “Structural determinants of Smad function in TGF-β signaling”. Trends in Biochemical Sciences 40 (6): 296–308. (June 2015). doi:10.1016/j.tibs.2015.03.012. PMC 4485443. PMID 25935112. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485443/. 
  7. ^ “Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads”. The EMBO Journal 20 (15): 4132–42. (August 2001). doi:10.1093/emboj/20.15.4132. PMC 149146. PMID 11483516. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC149146/. 
  8. ^ a b “Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling”. The Journal of Biological Chemistry 291 (1): 382–92. (January 2016). doi:10.1074/jbc.M115.694281. PMC 4697173. PMID 26555259. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697173/. 
  9. ^ a b c “Genetic characterization and cloning of mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster”. Genetics 139 (3): 1347–58. (March 1995). PMC 1206461. PMID 7768443. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1206461/. 
  10. ^ “Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor beta pathway components”. Proceedings of the National Academy of Sciences of the United States of America 93 (2): 790–4. (January 1996). Bibcode1996PNAS...93..790S. doi:10.1073/pnas.93.2.790. PMC 40134. PMID 8570636. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC40134/. 
  11. ^ “A human Mad protein acting as a BMP-regulated transcriptional activator”. Nature 381 (6583): 620–3. (June 1996). Bibcode1996Natur.381..620L. doi:10.1038/381620a0. PMID 8637600. 
  12. ^ a b “Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus”. Cell 113 (6): 685–700. (June 2003). doi:10.1016/S0092-8674(03)00432-X. PMID 12809600. 
  13. ^ “Structural determinants of Smad function in TGF-β signaling”. Trends in Biochemical Sciences 40 (6): 296–308. (June 2015). doi:10.1016/j.tibs.2015.03.012. PMC 4485443. PMID 25935112. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485443/. 
  14. ^ “Structural basis for genome wide recognition of 5-bp GC motifs by SMAD transcription factors”. Nature Communications 8 (1): 2070. (December 2017). Bibcode2017NatCo...8.2070M. doi:10.1038/s41467-017-02054-6. PMC 5727232. PMID 29234012. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727232/. 
  15. ^ “Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways”. Cell 139 (4): 757–69. (November 2009). doi:10.1016/j.cell.2009.09.035. PMC 2818353. PMID 19914168. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2818353/. 
  16. ^ “WW and SH3 domains, two different scaffolds to recognize proline-rich ligands”. FEBS Letters 513 (1): 30–7. (February 2002). doi:10.1016/S0014-5793(01)03290-2. PMID 11911877. 
  17. ^ “A Smad action turnover switch operated by WW domain readers of a phosphoserine code”. Genes & Development 25 (12): 1275–88. (June 2011). doi:10.1101/gad.2060811. PMC 3127429. PMID 21685363. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3127429/. .
  18. ^ “Structural basis for the versatile interactions of Smad7 with regulator WW domains in TGF-β Pathways”. Structure 20 (10): 1726–36. (October 2012). doi:10.1016/j.str.2012.07.014. PMC 3472128. PMID 22921829. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3472128/. 
  19. ^ “Emergence, development and diversification of the TGF-beta signalling pathway within the animal kingdom”. BMC Evolutionary Biology 9: 28. (February 2009). doi:10.1186/1471-2148-9-28. PMC 2657120. PMID 19192293. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2657120/. 
  20. ^ “The dawn of developmental signaling in the metazoa”. Cold Spring Harbor Symposia on Quantitative Biology 74: 81–90. (2009). doi:10.1101/sqb.2009.74.028. PMID 19903747. 
  21. ^ “Physical and functional interaction of murine and Xenopus Smad7 with bone morphogenetic protein receptors and transforming growth factor-beta receptors”. The Journal of Biological Chemistry 273 (39): 25364–70. (September 1998). doi:10.1074/jbc.273.39.25364. PMID 9738003. 
  22. ^ a b “Mechanisms of TGF-beta signaling from cell membrane to the nucleus”. Cell 113 (6): 685–700. (June 2003). doi:10.1016/s0092-8674(03)00432-x. PMID 12809600. 
  23. ^ “Structural basis of Smad1 activation by receptor kinase phosphorylation”. Molecular Cell 8 (6): 1303–12. (December 2001). doi:10.1016/s1097-2765(01)00417-8. PMID 11779505. 
  24. ^ “Smad2 nucleocytoplasmic shuttling by nucleoporins CAN/Nup214 and Nup153 feeds TGFbeta signaling complexes in the cytoplasm and nucleus”. Molecular Cell 10 (2): 271–82. (August 2002). doi:10.1016/s1097-2765(02)00586-5. PMID 12191473. 
  25. ^ “Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation”. Molecular and Cellular Biology 27 (12): 4488–99. (June 2007). doi:10.1128/MCB.01636-06. PMC 1900056. PMID 17438144. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1900056/. 
  26. ^ “Phosphorylation of Smad7 at Ser-249 does not interfere with its inhibitory role in transforming growth factor-beta-dependent signaling but affects Smad7-dependent transcriptional activation”. The Journal of Biological Chemistry 276 (17): 14344–9. (April 2001). doi:10.1074/jbc.M011019200. PMID 11278814. 
  27. ^ “Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer”. Nature Reviews. Cancer 3 (11): 807–21. (November 2003). doi:10.1038/nrc1208. PMID 14557817. 
  28. ^ “Myc downregulation by transforming growth factor beta required for activation of the p15(Ink4b) G(1) arrest pathway”. Molecular and Cellular Biology 19 (9): 5913–22. (September 1999). doi:10.1128/mcb.19.9.5913. PMC 84444. PMID 10454538. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC84444/. 
  29. ^ “E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression”. Cell 110 (1): 19–32. (July 2002). doi:10.1016/s0092-8674(02)00801-2. PMID 12150994. 
  30. ^ a b “The ID proteins: master regulators of cancer stem cells and tumour aggressiveness”. Nature Reviews. Cancer 14 (2): 77–91. (February 2014). doi:10.1038/nrc3638. PMID 24442143. 
  31. ^ “Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein”. Molecular and Cellular Biology 24 (10): 4241–54. (May 2004). doi:10.1128/mcb.24.10.4241-4254.2004. PMC 400464. PMID 15121845. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC400464/. 
  32. ^ “A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells”. Molecular Cell 11 (4): 915–26. (April 2003). doi:10.1016/s1097-2765(03)00109-6. PMID 12718878. 
  33. ^ “The endogenous ratio of Smad2 and Smad3 influences the cytostatic function of Smad3”. Molecular Biology of the Cell 16 (10): 4672–83. (October 2005). doi:10.1091/mbc.E05-01-0054. PMC 1237073. PMID 16093355. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1237073/. 
  34. ^ “Transcriptional control of cell cycle-dependent kinase 4 by Smad proteins--implications for Alzheimer's disease”. Neurobiology of Aging 33 (12): 2827–40. (December 2012). doi:10.1016/j.neurobiolaging.2012.01.013. PMID 22418736. 
  35. ^ “Alterations in the Smad pathway in human cancers”. Frontiers in Bioscience 17: 1281–93. (January 2012). doi:10.2741/3986. PMC 4281477. PMID 22201803. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281477/. 
  36. ^ a b “DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1”. Science 271 (5247): 350–3. (January 1996). Bibcode1996Sci...271..350H. doi:10.1126/science.271.5247.350. PMID 8553070. 
  37. ^ “Gastric and duodenal polyps in Smad4 (Dpc4) knockout mice”. Cancer Research 59 (24): 6113–7. (December 1999). PMID 10626800. 
  38. ^ “SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway” (英語). Proceedings of the National Academy of Sciences of the United States of America 98 (17): 9719–23. (August 2001). Bibcode2001PNAS...98.9719W. doi:10.1073/pnas.171321498. PMC 55519. PMID 11481457. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC55519/. 
  39. ^ “Alterations in components of the TGF-beta superfamily signaling pathways in human cancer”. Cytokine & Growth Factor Reviews 17 (1–2): 41–58. (February 2006). doi:10.1016/j.cytogfr.2005.09.009. PMID 16310402. 
  40. ^ “The consensus coding sequences of human breast and colorectal cancers”. Science 314 (5797): 268–74. (October 2006). Bibcode2006Sci...314..268S. doi:10.1126/science.1133427. PMID 16959974. 
  41. ^ “Ectopic expression of phospho-Smad2 in Alzheimer's disease: uncoupling of the transforming growth factor-beta pathway?” (英語). Journal of Neuroscience Research 84 (8): 1856–61. (December 2006). doi:10.1002/jnr.21072. PMID 16998902. 
  42. ^ “Altered subcellular location of phosphorylated Smads in Alzheimer's disease”. The European Journal of Neuroscience 24 (8): 2327–34. (October 2006). doi:10.1111/j.1460-9568.2006.05109.x. PMID 17074053. 
  43. ^ “Tau Pathology Promotes the Reorganization of the Extracellular Matrix and Inhibits the Formation of Perineuronal Nets by Regulating the Expression and the Distribution of Hyaluronic Acid Synthases”. Journal of Alzheimer's Disease 57 (2): 395–409. (2017). doi:10.3233/JAD-160804. PMC 5366250. PMID 28234253. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366250/. 
  44. ^ “Chronic kidney disease progression”. Journal of the American Society of Nephrology 17 (11): 2964–6. (November 2006). doi:10.1681/ASN.2006070704. PMID 17035605. 
  45. ^ “Mice overexpressing latent TGF-beta1 are protected against renal fibrosis in obstructive kidney disease”. American Journal of Physiology. Renal Physiology 295 (1): F118–27. (July 2008). doi:10.1152/ajprenal.00021.2008. PMC 2494503. PMID 18448597. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2494503/. 
  46. ^ “Renal fibrosis is not reduced by blocking transforming growth factor-β signaling in matrix-producing interstitial cells”. Kidney International 88 (3): 503–14. (September 2015). doi:10.1038/ki.2015.51. PMC 4556568. PMID 25760325. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556568/. 
  47. ^ “Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3” (英語). The Journal of Biological Chemistry 276 (42): 38502–10. (October 2001). doi:10.1074/jbc.M107081200. PMID 11502752. 
  48. ^ “TGF-beta signaling in renal disease”. Journal of the American Society of Nephrology 13 (10): 2600–10. (October 2002). doi:10.1097/01.asn.0000033611.79556.ae. PMID 12239251. 


「Smad」の続きの解説一覧

SMAD

出典: フリー百科事典『ウィキペディア(Wikipedia)』 (2021/04/22 04:16 UTC 版)

ナビゲーションに移動 検索に移動

SMAD





英和和英テキスト翻訳>> Weblio翻訳
英語⇒日本語日本語⇒英語
  
  •  Smadのページへのリンク

辞書ショートカット

すべての辞書の索引

「Smad」の関連用語

Smadのお隣キーワード
検索ランキング

   

英語⇒日本語
日本語⇒英語
   



Smadのページの著作権
Weblio 辞書 情報提供元は 参加元一覧 にて確認できます。

   
ウィキペディアウィキペディア
All text is available under the terms of the GNU Free Documentation License.
この記事は、ウィキペディアのSmad (改訂履歴)、SMAD (改訂履歴)の記事を複製、再配布したものにあたり、GNU Free Documentation Licenseというライセンスの下で提供されています。 Weblio辞書に掲載されているウィキペディアの記事も、全てGNU Free Documentation Licenseの元に提供されております。

©2024 GRAS Group, Inc.RSS